Inventor · disambiguated record
Michael Aaron Brodney
Also filed as: BRODNEY MICHAEL · BRODNEY MICHAEL A · BRODNEY MICHAEL AARON
63 granted patents·27 pending applications·465 citations·filing 2004–2024
99Inventor score
Top patents by PatentIndex Score
90 records- 0196US7795447B2Imidazole compounds for the treatment of neurodegenerative disordersPFIZER·Filed 2008·Granted Sep 14, 2010·50 cites·6 claims
- 0295US7951958B2Imidazole compounds for the treatment of neurodegenerative disordersPFIZER·Filed 2010·Granted May 31, 2011·28 cites·22 claims
- 0395US7342118B2Imidazole compounds for the treatment of neurodegenerative disordersPFIZER·Filed 2005·Granted Mar 11, 2008·38 cites·13 claims
- 0494US9315520B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2015·Granted Apr 19, 2016·15 cites·26 claims
- 0594US9198917B2Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2015·Granted Dec 1, 2015·14 cites·21 claims
- 0694US9107923B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Aug 18, 2015·11 cites·30 claims
- 0794US8822456B2Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2013·Granted Sep 2, 2014·19 cites·11 claims
- 0893US9527831B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2014·Granted Dec 27, 2016·13 cites·30 claims
- 0993US9428523B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2016·Granted Aug 30, 2016·12 cites·37 claims
- 1093US9192612B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2015·Granted Nov 24, 2015·13 cites·17 claims
- 1193US9139561B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Sep 22, 2015·8 cites·30 claims
- 1293US9045498B2Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Jun 2, 2015·18 cites·17 claims
- 1393US9045499B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Jun 2, 2015·17 cites·7 claims
- 1493US8865706B2Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Oct 21, 2014·19 cites·9 claims
- 1592US11866446B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·7 cites·55 claims
- 1692US8962616B2Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2013·Granted Feb 24, 2015·18 cites·18 claims
- 1791US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 1891US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 1991US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 2091US9822097B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2016·Granted Nov 21, 2017·6 cites·15 claims
- 2191US9605007B22-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2016·Granted Mar 28, 2017·8 cites·6 claims
- 2290US9845301B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2016·Granted Dec 19, 2017·8 cites·9 claims
- 2390US8933221B2Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsBRODNEY MICHAEL AARON·Filed 2012·Granted Jan 13, 2015·15 cites·4 claims
- 2489US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 2589US10604519B25,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2017·Granted Mar 31, 2020·3 cites·24 claims
- 2689US9233981B1Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2014·Granted Jan 12, 2016·12 cites·17 claims
- 2789US2024317713A1Heteroaromatic compounds and their use as dopamine d1 ligandsPFIZER·Filed 2024·Application pending·0 cites
- 2886US10093655B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2017·Granted Oct 9, 2018·3 cites·20 claims
- 2986US9540352B2Substituted 1,7-naphthyridines as dopamine D1 ligandsPFIZER·Filed 2015·Granted Jan 10, 2017·5 cites·26 claims
- 3086US7163942B2Sulfonamide compounds for the treatment of neurodegenerative disordersPFIZER·Filed 2005·Granted Jan 16, 2007·9 cites·18 claims
- 3185US10028962B22-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2017·Granted Jul 24, 2018·3 cites·40 claims
- 3285US9751895B2N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amidesPFIZER·Filed 2016·Granted Sep 5, 2017·3 cites·13 claims
- 3385US9611264B1N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amidesPFIZER·Filed 2016·Granted Apr 4, 2017·7 cites·24 claims
- 3485US9260455B2Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2013·Granted Feb 16, 2016·7 cites·13 claims
- 3585US7345095B2Sulfonamide compounds for the treatment of neurodegenerative disordersPFIZER·Filed 2006·Granted Mar 18, 2008·7 cites·2 claims
- 3685US7345038B2Pyridyloxymethyl and benzisoxazole azabicyclic derivativesPFIZER·Filed 2004·Granted Mar 18, 2008·25 cites·14 claims
- 3784US10421744B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2018·Granted Sep 24, 2019·2 cites·20 claims
- 3884US9403846B2Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsPFIZER·Filed 2013·Granted Aug 2, 2016·7 cites·19 claims
- 3983US10329308B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2018·Granted Jun 25, 2019·2 cites·23 claims
- 4083US2024190869A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2023·Application pending·0 cites
- 4182US10428034B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2017·Granted Oct 1, 2019·3 cites·18 claims
- 4282US9744173B22-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amidesPFIZER·Filed 2017·Granted Aug 29, 2017·2 cites·24 claims
- 4381US2023192690A15,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2023·Application pending·0 cites
- 4479US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 4579US10858373B2Heterocyclic spiro compounds as MAGL inhibitorsPFIZER·Filed 2019·Granted Dec 8, 2020·1 cites·17 claims
- 4679US7479559B2Benzyl(idene)-lactam derivativesPFIZER·Filed 2005·Granted Jan 20, 2009·6 cites·52 claims
- 4778US2025042878A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 4877US11964961B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 4977US11905284B25,7-dihydro-pyrrolo-pyridine derivativesPFIZER·Filed 2021·Granted Feb 20, 2024·0 cites·18 claims
- 5076US7781435B2Imidazole compounds for the treatment of neurological disordersPFIZER·Filed 2006·Granted Aug 24, 2010·2 cites·15 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Aaron Brodney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →